Holen Sie sich die Stockscreener-App
6.98
1.97%
-0.14
Schlusskurs vom Vortag:
$7.12
Offen:
$7.12
24-Stunden-Volumen:
1.63M
Relative Volume:
1.35
Marktkapitalisierung:
$397.83M
Einnahmen:
$5.82M
Nettoeinkommen (Verlust:
$71.18M
KGV:
6.9996
EPS:
0.9972
Netto-Cashflow:
$-84.30M
1W Leistung:
+9.06%
1M Leistung:
+30.22%
6M Leistung:
+34.49%
1J Leistung:
+19.32%
1-Tages-Spanne:
$6.7509
$7.25
1-Wochen-Bereich:
$6.22
$7.25
52-Wochen-Spanne:
$4.00
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Firmenname
Abeona Therapeutics Inc
Sektor
Branche
Telefon
646-813-4701
Adresse
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
6.98 | 397.83M | 5.82M | 71.18M | -84.30M | 0.9972 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-03-05 | Eingeleitet | Oppenheimer | Outperform |
| 2024-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-30 | Eingeleitet | Stifel | Buy |
| 2020-11-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-12-10 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2019-08-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2018-10-12 | Eingeleitet | Mizuho | Buy |
| 2018-06-05 | Eingeleitet | Seaport Global Securities | Buy |
| 2017-11-08 | Eingeleitet | SunTrust | Buy |
| 2017-10-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-11 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Eingeleitet | Citigroup | Buy |
| 2017-10-05 | Bestätigt | Maxim Group | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-18 | Bestätigt | Maxim Group | Buy |
| 2017-06-22 | Fortgesetzt | Jefferies | Buy |
| 2017-01-06 | Eingeleitet | Jefferies | Buy |
| 2016-09-29 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Abeona Therapeutics (NASDAQ: ABEO) shifts 760,870 warrants to SILV Fund - Stock Titan
Brendan O’Malley sells $83,912 in Abeona Therapeutics stock By Investing.com - Investing.com Australia
Form 4 Abeona Therapeutics Inc For: 9 July By Investing.com - Investing.com Nigeria
Abeona Therapeutics CEO Seshadri Vishwas sells $473k in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock - Investing.com UK
Abeona Therapeutics CEO Seshadri Vishwas sells $473k in stock - Investing.com
Abeona (ABEO) CFO sells 24,880 shares to cover taxes on vested stock - Stock Titan
Tax-related stock sale by Abeona (ABEO) CEO leaves 1.31M shares - Stock Titan
Abeona Therapeutics (ABEO) SVP sells shares to cover tax obligations - Stock Titan
Abeona Therapeutics (ABEO) CCO sells 12,606 shares, retains 290,623 - Stock Titan
Form 144 ABEONA THERAPEUTICS INC. For: 9 July By Investing.com - Investing.com South Africa
ABEO (NASDAQ) Form 144 shows 141,333 restricted shares planned for sale - Stock Titan
Insider share sales and RSAs reported by ABEO (NASDAQ: ABEO) - Stock Titan
ABEO (NASDAQ: ABEO) director reports proposed stock sales in Form 144 - Stock Titan
ABEO (Nasdaq: ABEO) files Form 144: 34,230 restricted shares; insider sales noted - Stock Titan
ABEO Q1 2026 Earnings: Narrowed Loss Surpasses Expectations as Stock Gains 3.82%Earnings Expansion Phase - dars.gov.et
ABEO (NASDAQ: ABEO) Rule 144 sale notice — 18,160 shares - Stock Titan
Abeona Therapeutics names Keith Goldan to board of directors - Investing.com
Price to sales forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Insider Sell Alert: Leila Alland Sells Shares of Abeona Therapeu - GuruFocus
Abeona Therapeutics (ABEO) director Alland Leila sells 11,000 shares - Stock Titan
ABEOAbeona Therapeutics Inc Latest SEC Filings - Finviz
Technical Reactions to ABEO Trends in Macro Strategies - Stock Traders Daily
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona gives 5 new hires restricted stock worth 9,000 shares - Stock Titan
Abeona Therapeutics Inc (ABEO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM: ABEO) added to Russell 2000 Value-Defensive Index - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to revenue forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to earnings forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to sales forward of Abeona Therapeutics, Inc. – HAM:PCJ - TradingView
ABEO Should I Buy - Intellectia AI
Enterprise value to EBITDA forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to earnings forward of Abeona Therapeutics, Inc. – HAM:PCJ - TradingView
Enterprise value to EBIT forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to book forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Top Growth Companies With Strong Insider Ownership For June 2026 - simplywall.st
Trading the Move, Not the Narrative: (ABEO) Edition - Stock Traders Daily
Abeona Therapeutics Inc (ABEO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Abeona Therapeutics Inc (ABEO) Institutional Confidence - TradingKey
Abeona Therapeutics Inc (ABEO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Abeona Therapeutics Inc (ABEO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Abeona Therapeutics Inc (ABEO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Abeona Therapeutics Inc (ABEO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Abeona Therapeutics Inc (ABEO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Abeona Therapeutics Inc (ABEO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Abeona Therapeutics (NASDAQ: ABEO) CCO has shares withheld for taxes on RSU vesting - Stock Titan
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):